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Abstract
Background: Many patients with chronic heart failure (CHF) receive treatment in primary care, but data have
shown that the quality of care for these patients needs to be improved. We aimed to evaluate the impact and
feasibility of a programme for improving primary care for patients with CHF.
Methods: An observational study was performed in 19 general practices in the south-eastern part of the
Netherlands, evaluation involving 15 general practitioners and 77 CHF patients. The programme for improvement
comprised educational and organizational components and was delivered by a trained practice visitor to the
practices. The evaluation was based on case registration forms completed by health professionals and telephone
interviews.
Results: Management relating to diet and physical exercise seemed to have improved as eight patients were
referred to dieticians and five to physiotherapists. The seasonal influenza vaccination rate increased from 94% to
97% (75/77). No impact on smoking was observed. Pharmaceutical treatment was adjusted according to guideline
recommendations in 12% of the patients (9/77); 7 patients started recommended medication and 2 patients
received dosage adjustments. General practitioners perceived the programme to be feasible. Clinical task
delegation to nurses and assistants increased in some practices, but collaboration with other healthcare providers
remained limited.
Conclusions: The improvement programme proved to have moderate impact on patient care. Its effectiveness
should be tested in a larger rigorous evaluation study using modifications based on the pilot experiences.
Background
Heart failure is a chronic disease, which has high preva-
lence, high burden for patients, high mortality, and high
costs of healthcare. The prevalence of chronic heart fail-
ure (CHF) in the western world is 1-2% in the general
population and 10% or higher in the age group of 85
years and older [1,2]. Hospitalization with CHF as main
diagnosis occurred in 2004 in 1.5 per 1.000 men and
women, and mortality rates in heart failure patients are
- with about 50% in 5 years - markedly higher compared
to their age group without heart failure [2,3].
International clinical guidelines for the management of
CHF provide comparable recommendations on diagno-
sis, treatment and lifestyle advice [4,5]. The recom-
mended pharmaceutical treatment is complex and
studies have reported suboptimal adherence to recom-
mended drug treatment [6-11]. Providing education and
counselling on lifestyle issues is recommended, despite
variable results. Many patients with CHF receive treat-
ment in outpatient hospital clinics settings and various
programmes have been developed to improve the treat-
ment in these settings [12]. However, in countries with
a strong primary care system, a large group of patients
with CHF receives treatment in primary care. This poses
specific challenges, as primary care physicians often
work in office-based practices, which may be less
equipped to provide structured care for CHF than spe-
cialised hospital departments. Therefore, we developed a
programme to improve primary care for CHF, compris-
ing educational and organizational components. The
programme included educational materials for physi-
cians to instruct them on the recently updated recom-
mendations on treatment, an algorithm which
summarized the recommendations, and educational
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materials for patients. The organizational components
comprised advice on organisational development of the
practice, particularly focused on delegation of clinical
tasks to practice assistants and nurses, which was deliv-
ered by a trained practice visitor. The underlying expec-
tation was that this multifaceted programme would
effectively improve patient care [13]. The aim of our
study was to examine the impact on patient care and
the feasibility of the programme.
Methods
Design
The study had a prospective observational design, with a
six-month follow up period. A mixed methods approach
was used, including both qualitative and quantitative
data-collection. Quantitative data included changes in
lifestyle advice and medication during the study period.
The medical ethical committee (CMO Regio Arnhem -
Nijmegen) assessed the study proposal and judged that
the study could be conducted without its approval.
Participants
The study population consisted of general practitioners
(GPs) recruited in two regions in the southeastern part
of the Netherlands. GPs were randomly selected from a
national list and then approached for this study. Partici-
pating GPs were asked to include patients with CHF
from their practice of whom the GPs considered them-
selves to be the physician taking care of the treatment
of this condition in the patient. On average, a GP in the
Netherlands has 25 patients listed with heart failure and
about half of them receive their CHF treatment in pri-
mary care [14,15].
Improvement programme
The programme comprised educational and organiza-
tional components, targeted at physicians, nurses and
assistants, and patients. The educational component
included a written summary of the non-pharmaceutical
and pharmaceutical treatment recommendations. The
information on non-pharmaceutical treatment con-
cerned physical exercise, diet, smoking cessation, influ-
enza vaccination, and materials to support advice to
patients. The information on pharmaceutical treatment
concerned the different drug groups advised: diuretics,
ACE inhibitors or ARBs, beta blocking agents, aldos-
teron blocking agent, and digoxin. The contents were
based on the prevailing Dutch College of General Practi-
tioners’ (DCGP) practice guideline on heart failure,
revised and issued in 2005 with new recommendations
on the use of ACE-inhibitors or angiotensin receptor
blockers (ARBs), and on beta-blocker treatment [16].
In addition, we developed a form that summarized the
various therapeutical options. We offered two-page case
registration forms on which the GP could register the
treatment at the start of the programme for each
individual patient. The first page of the form guided the
GP, nurse or practice assistant through the lifestyle
issues and recommended giving advice when appropri-
ate. The second page offered a stepwise overview
through the drug treatment options. Possible changes in
treatment could be noted. When a patient did not
receive a certain indicated treatment option a question
about the reason followed.
The organizational component of the programme
comprised tailored advice on the practice organisation.
Practices were encouraged to come to agreement about
collaboration with other care providers and on the dele-
gation of clinical tasks to nurses within the practice. To
support this, a model for cooperation and task delega-
tion was presented. We suggested that nurses and assis-
tants could give non-pharmaceutical advice and have
follow up contacts for monitoring side effects, blood
pressure and other relevant clinical parameters during
drug treatment titration. Also, in a stable phase periodi-
cal control visits could be delegated. A scheme was pro-
vided, offering an overview of tasks that could be
delegated and offering advised moments of consultation
with the GP. Furthermore, practices were encouraged to
build a structured organization of the care for heart fail-
ure patients, which included regularly planned contacts
with heart failure patients to evaluate their treatment,
on a 3-months basis in a stable phase and with 2 to 4
weeks intervals during medication adjustments. Another
organisational aspect of the improvement programme
was that practices were encouraged to establish colla-
boration with physiotherapists and dieticians.
All materials were included in a package: the educa-
tional material, supportive materials, information on
organisation, a scheme for task delegation, and the guid-
ing patient information form. A trained practice visitor
visited all practices. This practice visitor, a former prac-
tice assistant, was an experienced practice consultant
trained in data collection and supporting practices in
organizational changes. She clarified the project, intro-
duced the folder, and checked if practices were able to
select patients with heart failure appropriately. Six ran-
domly assigned practices were offered three extra visits
during the six-month period to study whether just intro-
ducing the material would be a feasible method and
whether follow-ups were considered useful by the parti-
cipating GPs. All other practices received one telephone
call after four weeks to check whether they managed to
fill in the patient registration forms. In follow up visits
practices were encouraged to make organisational
adjustments and to use the patient registration forms.
Throughout the project period a GP with specific
knowledge of treatment of CHF was available for ques-
tions raised by the participating GPs.
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Measures
Impact on patient care was assessed in terms of changes
in drug treatment and life style advice given during the
pilot period. This was based on the patient registration
forms, which were completed by the GP, nurse or prac-
tice assistant for each included patient. The measures
concerned treatment at the start of the programme,
information on non-pharmaceutical treatment and med-
ication changes with respect to heart failure during the
programme period of 6 months. Practices were asked to
send in anonymized duplicates of all patient registration
forms at the end of the project period.
The feasibility of the programme was assessed in
terms of GP reported experiences, using data from tele-
phone interviews at the end of the project period. Our
semi-structured questions focused on changes in colla-
boration with other care providers and task delegation
within the practice, on time spent by GPs for our pro-
gramme, and on the GPs views on the various compo-
nents of the programme.
Data-analysis
Results were categorized and presented descriptively.
Ethical approval
The medical ethical committee (CMO Regio Arnhem -
Nijmegen) assessed the study proposal and judged an
approval was not necessary.
Results
Sample
In total 654 GPs were informed about our project by
letter, of which 22 GPs agreed to participate in the
study. Three GPs dropped out because of lack of time.
Thirteen practices were visited just once at the project
start. Six practices were visited three times; after the
third visit they were offered another contact either by
telephone or a visit. They all decided an extra visit was
not necessary. When planning the telephone evaluations
4 GPs, all visited once, declared that they did not work
with the materials at all. Therefore they did not partici-
pate in the evaluation. So, finally, 15 GPs participated in
the evaluation; 10 of them sent in 77 patient registration
forms. All GPs were able to select patients using ICPC
codes. Table 1 summarizes these data. The study period
was from October 2007 until April 2008.
Table 2 shows data on the 19 participating GPs and
their practices and Table 3 shows demographic data of
the patients included. All but one participating practices
had one or more practice nurses. In seven practices
these nurses already had clinical tasks in CHF care.
Most GPs judged the DCGP’s clinical practice guideline
programme in general and the guideline on CHF in par-
ticular, positively. Involvement of a dietician or a phy-
siotherapist in the care for heart failure patients was
formalized in three and two practices respectively. Ele-
ven GPs reported formal involvement of a cardiologist,
one reported formal involvement of a heart failure nurse
and one involved a heart failure outpatient clinic.
The patient sample included slightly more females
(58%) than males, and the mean age was 78. About one
third of the patients (37%) was in NYHA class III or IV,
indicating more severe CHF. The GPs reported hyper-
tension as one of the causes of heart failure in 57% of
the patients and coronary heart disease in 47%.
The expert GP had telephone contacts with 3 GPs and
email contacts with another 3 practices. One of the par-
ticipating GPs had questions considering treating octo-
genarians; other issues were organizational.
Impact
Table 4 shows the impact on lifestyle advice and drug
treatment. Eight out of the 17 patients who received
(renewed) dietary advice eight were referred to a dieti-
cian. Also, out of 28 patients who were advised on phy-
sical activity 5 patients were referred for physical activity
therapy. Seasonal influenza vaccination grade was
already high (94%, 72/77), but during the winter in the
project period another three more patients were vacci-
nated. Of the patients registered as smokers 4 were
(again) advised to stop smoking. None of them actually
quitted smoking.
In 4 patients their GP started a diuretic and in 3
patients an ACE inhibitor or ARB in accordance with
the recommendations. Furthermore, in one patient ACE
Table 1 Flow of included practices and patients.
Group 1
(three visits)
Group 2
(one visit)
Total
Included practices 7 15 22
Refused to participate 1 2 3
Participating practices 6 13 19
Number of practices participating in
the evaluation
6 9 15
Number of practices returning
patient information forms
5 5 10
Number of patient registration
forms
35 (4-10) 42 (4-10) 77 (4-10)
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inhibitor dosage was optimized. Although just over half
of the patients were treated with a beta-blocker, the GPs
did not start beta-blocker treatment with any patient.
On the patient registration, all patients with beta-block-
ers indicated but not prescribed were said to have a
contra indication. In one patient the beta-blocker dosage
was optimized. In total, medication was adjusted in 9
patients (12%).
Feasibility
All elements of the programme were evaluated positively
by the vast majority of the 15 GPs involved in the eva-
luation. Of them, 14 had positive judgements about
both the written materials and the practice visits, and 12
about the patient registration forms. Thirteen GPs
would advise colleagues to participate in this heart fail-
ure programme and would participate in a programme
like this again. The mean time investment for the GP
was 2.5 hours, ranging from 0.5 to 5 hours.
Six GPs made organisational changes in the manage-
ment of chronic heart failure care. Only a few GPs con-
sidered cooperation with other disciplines in the care
improved: three GPs with a dietician, one with a phy-
siotherapist, and one with a cardiologist. Nine GPs con-
sidered care for heart failure patients in their practice as
improved.
In the group with repeated visits all practices were
satisfied in their need for support after 3 visits although
another follow up visit was offered. One GP thought the
support was more than necessary. In the group with just
one practice visit 4 GPs would have welcomed more
support; the other 5 GPs were satisfied with just one
visit.
Discussion
Main conclusions
The programme to improve primary care for patients
with CHF proved to be feasible and to be associated
with clinically relevant improvements in at least some
patients, particularly regarding lifestyle advice. All com-
ponents of the programme - the written material includ-
ing the patient registration forms and the practice visits
by the outreach visitor - were positively assessed. There
was no clear optimum number of visits by the practice
visitor (one or three). Obviously, the need for visits will
differ between practices. In a number of practices one
practice visit did not suffice, as in the group of 13 prac-
tices that were visited once only 9 GPs finally worked
with the materials provided, and 4 of these 9 GPs con-
sidered support with one visit insufficient.
Interpretation
Especially in specialist medical care, there have been
several initiatives for improving healthcare for patients
with CHF. Many of these programmes include more fre-
quent contacts with the patients by specialized heart
failure nurses than usual care provides. The outcomes
of these heart failure programmes were not consistent
[17-19].
A limited number of randomised controlled trials eval-
uated improvement programmes for the treatment of
heart failure in primary care [20-24]. Interventions con-
sisted of nurse-led contacts, computer based treatment
suggestions, practice guideline recommendations and
disease management programmes, for instance. Again,
outcomes were not consistent, with significant differ-
ences in some endpoints defined, but not in all. There-
fore, also in primary care, further effort is necessary to
develop effective improvement programmes.
Our programme aimed to achieve changes by reducing
various types of barriers for change, the complexity of
the prevailing practice guideline with recently changed
treatment recommendations being one. Therefore we
provided educational interventions. Secondly, in CHF
care there was no structured approach as there is in dia-
betes care. We proposed organizational interventions,
which were tailored to the practice. Although the impact
of tailoring and combining interventions has not been
found to be consistently more effective than single inter-
ventions [13], many experts have proposed that these
two aspects contribute to the effectiveness of
Table 2 Baseline characteristics of the general practices
(total n = 19).
N %
Number of GPs in the
practice:
Solo practice 12 63
Duo practice 5 26
Group practice 2 11
Number of practices
with practice support
18 95
Practice supportive staff
member with tasks in
heart failure
7 37
Number of practices
accreditated
5 26
Agreement with
contents of heart failure
practice guideline
16 84
Positive attitude
towards practice
guidelines in general
17 89
Formalized cooperation
with dietician
3 16
Formalized cooperation
with physiotherapist
2 11
Formalized cooperation
with cardiologist
11 58
Formalized cooperation
with others (heart
failure nurse, heart
failure outpatient clinic)
2 11
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programmes for improving healthcare [25]. A problem,
however, is that tailoring interventions to organizational
barriers is difficult [26].
Our patient sample seemed to represent the popula-
tion quite well, considering sex, age, pathology underly-
ing CHF, and co-morbidity [8,11]. The rather high
percentage of NYHA class III or IV (37%) might be
unexpected in primary care. Yet, especially in the group
of old and severely ill, patients usually do not visit the
outpatient clinic and are treated in primary care with
home visits.
Several studies showed that pharmaceutical treatment
of heart failure patients in general practices is not opti-
mal. Forty to 78% of the heart failure patients were trea-
ted with an ACE-inhibitor or ARB [6-11]. In our sample
82% of the patients were using an ACE-inhibitor or
ARB. The use of beta-blockers in previous studies varied
from 7 to 32% [8,10,11]. In our study 56% of the
patients used a beta-blocking agent. Our relatively high
percentages may indicate a selection of practices or
patients, but may also reflect the fact that our data were
collected more recently. Revised practice guideline
recommendations for Dutch GPs have been published
in 2005. Though treatment was good already there was
still room for improvement, and the percentage of
patients who received improved care reflects percentages
found in previous studies of implementation interven-
tions [27].
We did not find much change in formalized interdisci-
plinary cooperation with other care providers. Our pro-
gramme did not contain supportive materials for
improvement of interdisciplinary cooperation (for
instance with dieticians). This clearly has to be
addressed in further development of the programme,
Table 3 Patient characteristics at baseline (n = 77).
n = 77 %
Sex
Male 32 42
Female 44 58
Mean age (youngest and oldest) 78
sd 10,3
(44-92)
Years since diagnosis on average 6
NYHA class
I 16 23
II 29 41
III 19 27
IV 7 10
Smoking
Yes 9 13
No 60 87
Causes of heart failure (more than one possible):
- Coronary heart disease 36 47
- Hypertension 44 57
- Others (e.g. rhythm disorders) 19 25
Co morbidity
- Myocardial infarction in medical history 16 21
- Angina pectoris 25 32
- CABG or PCI in medical history 8 10
- Hypertension 34 44
- Asthma 3 4
- COPD 13 17
- Diabetes mellitus 24 31
- Hypothyroid disease 3 4
- Hyperthyroid disease 3 4
- Rhythm disorders, e.g. atrial fibrillation 11 14
- Others 52 68
Percentages are from the forms with data on the question, ignoring forms with missing data.
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following for instance a comprehensive tool with a list
of tasks to make interdisciplinary cooperation agreement
made by The Dutch Heart Foundation [28].
Strengths and weaknesses
We carefully developed a programme for improving pri-
mary care for CHF patients, and tested this in real prac-
tice. This is an important step in the development of
effective interventions, which is often overlooked. A ser-
ious limitation of our study is the practice sample and
the patient sample size. The sample of practices is non-
random due to the low response rate, and the patient
sample is small (77 patients included) because only 10
GPs sent back the registration forms. Generalizing
results beyond the practices and patients studied is pro-
blematic, but for the purpose of this study this was
regarded as acceptable.
The strength of our programme is the fact that it is
multifaceted, addressing organizational and educational
aspects with a variety of materials and visits. Especially,
the patient registration form with an algorithm was
guiding and very helpful.
Implications for research, policy and practice
Some aspects of the programme can be improved, parti-
cularly regarding collaboration with other care provi-
ders, making use of existing materials. Our programme
was entirely focussed on treatment; medical education
on the diagnostic work up could serve as a starting
point for a kick off of the programme. The programme
held many elements. A barrier analysis in each partici-
pating practice could identify the need for specific ele-
ments and form the basis of a tailored made
intervention. Within one region other disciplines could
be invited to participate, reinforcing treatment in pri-
mary care in general. Also, cooperation with cardiolo-
gists could be enforced with local agreement meetings
on diagnostic procedures, referral and referring back to
primary care, and shared care. In such a new approach
the programme should be evaluated again. Then, the
major challenge is to make the programme available for
larger groups of primary care practices. The programme
could gain strength with a more regional approach,
which would give opportunities for cooperation espe-
cially when functioning regional organisations or struc-
tures are available.
Conclusion
A feasible and promising programme for improving pri-
mary care for patients with CHF is now available. Its
effectiveness needs to be tested in a larger study after
making programme adjustments taking advantage of the
lessons learned in this pilot study. Further implementa-
tion of the programme could be organized on a regional
level. Extra attention should be paid to cooperation with
other disciplines and to making use of existing struc-
tures within these regions.
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